Ligand Pharmaceuticals Inc (LGND)
87.12
+1.00
(+1.16%)
USD |
NASDAQ |
May 10, 16:00
87.12
0.00 (0.00%)
After-Hours: 18:44
Ligand Pharmaceuticals Market Cap: 1.565B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 1.547B |
| May 08, 2024 | 1.444B |
| May 07, 2024 | 1.315B |
| May 06, 2024 | 1.308B |
| May 03, 2024 | 1.327B |
| May 02, 2024 | 1.299B |
| May 01, 2024 | 1.283B |
| April 30, 2024 | 1.255B |
| April 29, 2024 | 1.265B |
| April 26, 2024 | 1.267B |
| April 25, 2024 | 1.264B |
| April 24, 2024 | 1.275B |
| April 23, 2024 | 1.255B |
| April 22, 2024 | 1.231B |
| April 19, 2024 | 1.301B |
| April 18, 2024 | 1.300B |
| April 17, 2024 | 1.414B |
| April 16, 2024 | 1.432B |
| April 15, 2024 | 1.430B |
| April 12, 2024 | 1.458B |
| April 11, 2024 | 1.460B |
| April 10, 2024 | 1.448B |
| April 09, 2024 | 1.461B |
| April 08, 2024 | 1.427B |
| April 05, 2024 | 1.397B |
| Date | Value |
|---|---|
| April 04, 2024 | 1.398B |
| April 03, 2024 | 1.339B |
| April 02, 2024 | 1.312B |
| April 01, 2024 | 1.319B |
| March 28, 2024 | 1.294B |
| March 27, 2024 | 1.262B |
| March 26, 2024 | 1.215B |
| March 25, 2024 | 1.226B |
| March 22, 2024 | 1.257B |
| March 21, 2024 | 1.292B |
| March 20, 2024 | 1.294B |
| March 19, 2024 | 1.278B |
| March 18, 2024 | 1.277B |
| March 15, 2024 | 1.259B |
| March 14, 2024 | 1.274B |
| March 13, 2024 | 1.288B |
| March 12, 2024 | 1.281B |
| March 11, 2024 | 1.279B |
| March 08, 2024 | 1.306B |
| March 07, 2024 | 1.283B |
| March 06, 2024 | 1.287B |
| March 05, 2024 | 1.310B |
| March 04, 2024 | 1.351B |
| March 01, 2024 | 1.393B |
| February 29, 2024 | 1.405B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
863.56M
Minimum
Oct 27 2023
3.471B
Maximum
Feb 09 2021
1.681B
Average
1.618B
Median
Market Cap Benchmarks
| ANI Pharmaceuticals Inc | 1.433B |
| ADMA Biologics Inc | 2.011B |
| Viking Therapeutics Inc | 8.122B |
| Voyager Therapeutics Inc | 458.22M |
| Palatin Technologies Inc | 36.63M |
Market Cap Related Metrics
| PE Ratio | 16.38 |
| PS Ratio | 13.05 |
| PEG Ratio | 0.0508 |
| Price to Book Value | 1.940 |
| Price | 87.12 |
| Earnings Yield | 6.11% |
| PEGY Ratio | 0.0508 |
| Normalized PE Ratio | 271.44 |